| Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ... The Lancet 396 (10253), 759-769, 2020 | 911 | 2020 |
| Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term MortalityClinical Perspective TC Wong, K Piehler, CG Meier, SM Testa, AM Klock, AA Aneizi, ... Circulation 126 (10), 1206-1216, 2012 | 568 | 2012 |
| Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission TC Wong, KM Piehler, IA Kang, A Kadakkal, P Kellman, DS Schwartzman, ... European Heart Journal, 2013 | 428 | 2013 |
| Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy CY Ho, ME Mealiffe, RG Bach, M Bhattacharya, L Choudhury, ... Journal of the American College of Cardiology 75 (21), 2649-2660, 2020 | 301 | 2020 |
| Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus EB Schelbert, SM Testa, CG Meier, WJ Ceyrolles, JE Levenson, AJ Blair, ... Journal of cardiovascular magnetic resonance 13 (1), 16, 2011 | 274 | 2011 |
| Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction … WTC Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR ... J Am Heart Assoc. 18, 2015 | 255* | 2015 |
| Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome S EB, F Y, W TC, A Daya H, P KM, K A, M CA, U M, M M, K P, S DJ, A KZ, ... JAMA Cardiology, 2017 | 210 | 2017 |
| Automatic Measurement of the Myocardial Interstitium: Synthetic Extracellular Volume Quantification Without Hematocrit Sampling. MJC Treibel TA, Fontana M, Maestrini V, Castelletti S, Rosmini S, Simpson J ... JACC Cardiovasc Imaging, 2016 | 181 | 2016 |
| Phase 2 study of aficamten in patients with obstructive hypertrophic cardiomyopathy MS Maron, A Masri, L Choudhury, I Olivotto, S Saberi, A Wang, ... Journal of the American College of Cardiology 81 (1), 34-45, 2023 | 152 | 2023 |
| Splenic Switch-off: A Tool to Assess Stress Adequacy in Adenosine Perfusion Cardiac MR Imaging. MJC Manisty C, Ripley DP, Herrey AS, Captur G, Wong TC, Petersen SE, Plein S ... Radiology, 2015 | 113 | 2015 |
| Extracellular volume associates with outcomes more strongly than native or post-contrast myocardial T1 TA Treibel, Y Fridman, P Bering, A Sayeed, M Maanja, F Frojdh, ... Cardiovascular Imaging 13 (1_Part_1), 44-54, 2020 | 103 | 2020 |
| Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection S Kelle, C Bucciarelli-Ducci, RM Judd, RY Kwong, O Simonetti, S Plein, ... Journal of Cardiovascular Magnetic Resonance 22, 1-4, 2020 | 85 | 2020 |
| Free-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients KM Piehler, TC Wong, KS Puntil, KM Zareba, K Lin, DM Harris, CR Deible, ... Circulation: Cardiovascular Imaging 6 (3), 423-432, 2013 | 83 | 2013 |
| Vigorous exercise in patients with hypertrophic cardiomyopathy R Lampert, MJ Ackerman, BS Marino, M Burg, B Ainsworth, L Salberg, ... JAMA cardiology 8 (6), 595-605, 2023 | 78 | 2023 |
| Efficient 1-hour technetium-99 m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis A Masri, S Bukhari, S Ahmad, R Nieves, YS Eisele, W Follansbee, ... Circulation: Cardiovascular Imaging 13 (2), e010249, 2020 | 73 | 2020 |
| Diagnostic Performance of Treadmill Exercise Cardiac Magnetic Resonance: The Prospective, Multicenter Exercise CMR's Accuracy for Cardiovascular Stress Testing (EXACT) Trial. SOP Raman SV, Dickerson JA, Mazur W, Wong TC, B Schelbert E, Min JK ... J Am Heart Assoc, 2016 | 59* | 2016 |
| Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass UM Maanja M, Wieslander B, Schlegel TT, Bacharova L, Abu Daya H, Fridman Y ... Journal of the American Heart Association 6 (1), 2017 | 56 | 2017 |
| Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure TC Wong, KM Piehler, KM Zareba, K Lin, A Phrampus, A Patel, JC Moon, ... Journal of the American Heart Association 2 (6), e000416, 2013 | 56 | 2013 |
| Advances in Multimodality Imaging in Cardio-Oncology: JACC State-of-the-Art Review LA Baldassarre, S Ganatra, J Lopez-Mattei, EH Yang, VG Zaha, TC Wong, ... Journal of the American College of Cardiology 80 (16), 1560-1578, 2022 | 55 | 2022 |
| Extracellular volume and global longitudinal strain both associate with outcomes but correlate minimally F Fröjdh, Y Fridman, P Bering, A Sayeed, M Maanja, L Niklasson, ... Cardiovascular Imaging 13 (11), 2343-2354, 2020 | 55 | 2020 |
Erik Schelbert, MD, MSMinneapolis Heart InstituteVerified email at allina.com
